Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» kidney cancer
kidney cancer
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Fierce Pharma
Fri, 01/12/18 - 06:39 pm
Merck
Eisai
Keytruda
Lenvima
kidney cancer
Pfizer defends kidney-cancer position with Bavencio 'breakthrough'
Fierce Pharma
Wed, 01/3/18 - 10:58 am
Pfizer
kidney cancer
Bavencio
Merck KGaA
Pfizer, Exelixis cancer drugs get FDA approval for wider use
Reuters
Wed, 12/20/17 - 09:39 am
Pfizer
Exelixis
Cabometyx
kidney cancer
Bosulif
blood cancer
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
cancer
labeling
AstraZeneca
Faslodex
Pfizer
Sutent
kidney cancer
Roche
Gazyva
follicular lymphoma
Bristol-Myers Squibb could double patient numbers for Opdivo in kidney cancer
Fierce Pharma
Wed, 11/1/17 - 11:04 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Pfizer hits a snag in bid to jump-start Sutent's flagging kidney cancer sales
Fierce Pharma
Thu, 09/21/17 - 10:02 pm
Pfizer
Sutent
kidney cancer
Ipsen focuses on oncology to keep growing
GoInPharma
Mon, 09/18/17 - 09:24 am
Ipsen
oncology
Xermelo
kidney cancer
Exelixis, Inc. and Bristol-Myers Squibb Co. Gear Up for Round 2 of the Kidney Cancer Drug Battle Royale
Motley Fool
Thu, 09/14/17 - 06:56 pm
Exelixis
Bristol-Myers Squibb
kidney cancer
Cabometyx
Opdivo
Yervoy
Opdivo combo shows early survival benefit in kidney cancer
BioPharma Dive
Fri, 09/8/17 - 09:34 am
Opdivo
Yervoy
Bristol-Myers Squibb
kidney cancer
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer
Xconomy
Wed, 08/16/17 - 10:13 am
Bristol-Myers Squibb
kidney cancer
Opdivo
Yervoy
Aveo soars as long-beleaguered cancer drug nears approval
Fierce Biotech
Sat, 06/24/17 - 09:23 am
Aveo
Europe
tivozanib
kidney cancer
Acceleron dumps dalantercept after kidney cancer trial fail
Fierce Biotech
Tue, 06/13/17 - 11:57 am
Acceleron
dalantercept
kidney cancer
clinical trials
Roche says Phase II trial supports twin treatment for kidney cancer
Yahoo/Reuters
Sat, 02/18/17 - 02:35 pm
Roche
kidney cancer
Tecentriq
What's Pfizer's Excuse for Not Buying Exelixis?
Motley Fool
Wed, 11/30/16 - 09:46 pm
Pfizer
Exelixis
M&A
Cabometyx
kidney cancer
Sutent
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
Motley Fool
Mon, 10/17/16 - 11:49 am
Pfizer
Bristol-Myers Squibb
Exelixis
Cabometyx
kidney cancer
Sutent
Opdivo
Exelixis and Pfizer drugs compete in kidney cancer trial
Yahoo/Reuters
Mon, 10/10/16 - 09:15 am
kidney cancer
Exelixis
Pfizer
Sutent
Cabometyx
Pfizer's Sutent comes up big in adjuvant trial, staving off cancer for 6 years-plus
Fierce Pharma
Mon, 10/10/16 - 09:08 am
Pfizer
Sutent
kidney cancer
Here's How Pfizer's Protecting Its Kidney Cancer Drug From New Competitors
Motley Fool
Sun, 07/10/16 - 11:59 am
Pfizer
Sutent
kidney cancer
Exelixis
Bristol-Myers Squibb
Novartis
UK cost agency rejects Bristol's Opdivo for kidney cancer
Yahoo/Reuters
Tue, 07/5/16 - 10:23 am
UK
Bristol-Myers Squibb
Opdivo
kidney cancer
NICE
Eisai's kidney drug wins expanded indication in the U.S.
BioPharma Dive
Tue, 05/17/16 - 09:35 am
Eisai
advanced renal cell carcinoma
kidney cancer
Lenvima
RCC
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »